Earth Science Tech Leverages Vertically Integrated Healthcare Platform for Dilution-Free Growth
July 28th, 2026 1:05 PM
By: Newsworthy Staff
Earth Science Tech Inc. uses its compounding pharmacy and telemedicine subsidiaries to drive cash-flow-driven, dilution-free growth by reducing liabilities and increasing assets.

Earth Science Tech Inc. (OTC: ETST) is capitalizing on its diversified, synergistic operations to deliver dilution-free and cash-flow-driven growth through a vertically integrated healthcare platform. The company, through its specialized subsidiaries RxCompoundStore, Mister Meds, and Peaks Curative LLC, has created a dual-market operation that reduces reliance on any single market segment. This integration combines compounding pharmacy operations, telemedicine, clinical support, and fulfillment, allowing Earth Science Tech to serve both wholesale and direct-to-consumer markets effectively.
RxCompoundStore, a Miami-based licensed compounding pharmacy, produces sterile and non-sterile custom medications. Mister Meds, based in Abilene, Texas, focuses on sterile medications and hazardous drugs. These pharmacies compound ingredients into custom medications, which are supplied wholesale to independent clinics and directly to consumers through Peaks Curative LLC. This dual-market approach ensures steady revenue streams and reduces dependency on one segment.
In fiscal year 2026, Earth Science Tech demonstrated financial strength by reducing total liabilities and increasing total assets, resulting in a net increase in shareholder equity. This achievement underscores the company's commitment to dilution-free growth, meaning it does not rely on issuing new shares to raise capital, thereby protecting shareholder value. The company's cash-flow-driven model ensures that operations fund expansion rather than external financing.
The synergy among subsidiaries creates efficiencies that lower costs and improve margins. By controlling the supply chain from compounding to patient delivery, Earth Science Tech captures value at each stage. This vertical integration also enhances quality control and patient outcomes, as medications are tailored to individual needs.
For more details, the latest news and updates relating to ETST are available in the company’s newsroom at https://ibn.fm/ETST. Investors can also find additional information through InvestorWire, a specialized communications platform that syndicates press releases to a wide audience. InvestorWire is part of the Dynamic Brand Portfolio @IBN, which provides access to a vast network of wire solutions, article syndication to 5,000+ outlets, and social media distribution. For more information, visit https://www.InvestorWire.com. Please see full terms of use and disclaimers on the InvestorWire website at https://www.InvestorWire.com/Disclaimer.
The company's strategic focus on vertical integration and financial discipline positions it for sustainable growth. By leveraging its compounding pharmacy operations and telemedicine capabilities, Earth Science Tech is building a healthcare platform that meets the evolving needs of patients and providers. This approach not only drives revenue but also enhances shareholder value through prudent financial management.
Source Statement
This news article relied primarily on a press release disributed by InvestorBrandNetwork (IBN). You can read the source press release here,
